期刊文献+

前列腺增生电切术后二次电切20例分析 被引量:4

ANALYSIS ON THE 20 CASES ACCEPTED THE SECOND TRANSURETHRAL RESECTION OF PROSTATE FOLLOWING THE FIRST TURP
下载PDF
导出
摘要 目的探讨良性前列腺增生(BPH)经尿道前列腺电切(TURP)术后再次出现排尿困难并需要第二次电切的发生原因及处理方法。方法回顾性分析20例良性前列腺增生TURP术后排尿困难行第二次电切术的病例资料。结果根据不同的病因采取不同的手术方式及后续治疗,痊愈17例,耻骨上膀胱造瘘2例,1例死亡。结论正确的术前诊断,依据不同的病因选择对应的手术方式、加强术后处理,必要的术后随访,是第二次手术成功并提高老年人生活质量的关键,同时也是进一步减少第二次手术机会的关键。 Objective To discuss causes and treatment for the dysuria that needed a second transurethral re- section of prostate(TURP) following the first TURP on benign prostate hyperplasia (BPH). Methods 20 cases who have recurent dysuria received second TURP, the clinical data was retrospectively analysised. Results According to the different condition, appropriate treatment was admitted to these patients. In a follow -up of about 24 months, 17 cases cured, suprapubic cystostomy in 2 cases, 1 patient died. Conclusion Correct preoperative diagnosis, proper treatment according to the different condition, rigorous postoperative regulation and follow up, was the key step to en- hance the quality of life for these patients, and decrease the necessary for second TURP.
出处 《现代医院》 2013年第1期31-32,共2页 Modern Hospitals
关键词 前列腺增生 TURP 二次手术 benign prostatic hyperplasia, transurethral resection of prostate, second TURP
  • 相关文献

参考文献6

二级参考文献17

共引文献55

同被引文献32

  • 1孙颖浩,侯建国,许传亮,汤昊,高旭,高小峰,张振声,杨波,王林辉.铥激光前列腺切除术治疗良性前列腺增生(附32例报告)[J].中国微创外科杂志,2007,7(8):740-742. 被引量:18
  • 2NICKEL JC, DOWNEY I, YOUNG I, et al. Asymptomatic in- flammation and/or infection in benign prostatic hyperplasia [ J ]. BJU Int, 1999, 84:976-981.
  • 3GERSTENBLUTH R E, STEI3'EL A D, MACLENNAN G T, et al. Distribution of chrinic prostatitis in radical prostatectomy spec- imens with up - regulation of Bcl - 2 in areas of inflammation[ J]. Urol, 2002, 167(5) :2267 -2270.
  • 4KRIEGER J N, RILEY D E, CHEAH P Y. Epidemiology of pros- tatitis : new evidence for a world - wide problem [ J ]. Urol, 2003, 21(2) :70-74.
  • 5GLEASON P E. Platelet derived growth factor(PDGF) ,androgens and inflammation: possible etiologic factors in the development of prostatic hyperplasia[ J ]. Urol, 1993, 149 (6) 1586 - 1592.
  • 6MARK A, PULLEN, KATHERINE THOMAS, et al. Stimulation of hyaluronan synthetase by platelet - derived growth factor bb in human prostate smooth muscle cells [ J]. Pharmacology, 2001, 62 : 103 - 106.
  • 7WANG W, BERGH A, DAMBER J E. Chronic inflammation in benign prostate hyperptasia is associated weth focal up regulation of cyclooxygenase - 2, Bcl - 2, and cell proliferation in the glandular epithelium[ J]. Prostate, 2004, 61:60 - 72.
  • 8SCHOBER A, BOTTNER M, STRELAU J, et al. Expression of growth differentiation factor - 15/macrophage inhibitory cytokine - 1 ( GDF - 15/MIC - 1 ) in the perinatal adult and injured rat brain [ J ]. Comp Neurol, 2001,439:32 - 45.
  • 9TAOKA R, TSUKUDA F, ISHIKAWA M, et al. Association ofprostatic inflammation with down - regulation of macrophage inhib- itory cytokine - 1 gene in symptomatic benign prostatic hyperplasia [J]. Urol, 2004, 171:2330-2335.
  • 10Tinel H, Stelte-Ludwig B, Hatter J, et al. Pre-clinical evidence for the use of phosphodiesterase-5 inhibitors for treating benign prostatic hyperplasia and lower urinary tract symptoms[J]. BJU Int, 2006, 98(6) : 1259-1263.

引证文献4

二级引证文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部